D70.1 Agranulocytosis secondary to cancer chemotherapy

Use Additional:

Code For Adverse Effect, If Applicable, To Identify Drug (T45.1X5)

The following code(s) above D70.1 may contain annotation back-references that may be applicable to D70.1:

• Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)

Diagnosis Index

Agranulocytosis D70.9 - see also Neutropenia
- Cytoreductive Cancer Chemotherapy Sequela D70.1
- Drug-induced D70.2
-- Due To Cytoreductive Cancer Chemotherapy D70.1
- Secondary D70.4
-- Drug-induced D70.2
--- Due To Cytoreductive Cancer Chemotherapy D70.1
Leukopenia D72.819
- Chemotherapy Induced D70.1
- Drug Induced NEC D70.2
-- Due To Cytoreductive Cancer Chemotherapy D70.1
Neutropenia, Neutropenic D70.9
- Cytoreductive Cancer Chemotherapy Sequela D70.1
- Drug-induced D70.2
-- Due To Cytoreductive Cancer Chemotherapy D70.1
- Secondary D70.4
-- Drug-induced D70.2
--- Due To Cytoreductive Cancer Chemotherapy D70.1